Enthea, led by CEO Sherry Rais, is a Boston, MA–based licensed provider of health insurance benefits that cover psychedelic-assisted psychotherapies. The company offers workplace benefit plans that enable employers to provide coverage for PAP to treat a wide range of mental health conditions. Its medical policies are evidence-based and guided by expert panels. Enthea currently covers ketamine-based treatments and plans to add MDMA and psilocybin medicines as they are approved. The company is building a nationwide network of credentialed clinics and therapists, opening in 40 U.S. cities in 2023 and intends to launch services into 40 markets across the U.S. next year. Enthea raised seed funding to grow its customer base and provider network.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2022